TRIM21 Knockout HeLa Cell Line
Cat.No.:
EDC90404
Species:
Human
Cell Name:
HeLa
Gene:
TRIM21
Gene ID:
6737
Size:
1×10⁶cells
TRIM21 Knockout Cell Line (Hela) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC90404 |
|---|---|
| Product Name | TRIM21 Knockout Hela Cell Line |
| Cell Line | Hela |
| Cellosaurus ID | CVCL_0030 |
| Cell Line Synonyms | HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
| Gene | TRIM21 |
| NCBI Gene ID | |
| Gene Synonyms | RNF81|RO52|Ro/SSA|SSA|SSA1 |
| Summary |
This gene encodes a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The encoded protein is part of the RoSSA ribonucleoprotein, which includes a single polypeptide and one of four small RNA molecules. The RoSSA particle localizes to both the cytoplasm and the nucleus. RoSSA interacts with autoantigens in patients with Sjogren syndrome and systemic lupus erythematosus. Alternatively spliced transcript variants for this gene have been described but the full-length nature of only one has been determined. [provided by RefSeq, Jul 2008]
|
| Associated Diseases | Cervical Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1/5, 2days |
| Complete Culture Medium | MEM + 10% FBS |
| Freezing Medium | 70%Complete culture medium+ 20% FBS+ 10% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HeLa | STR Info (Cell bank) Cell Line: HeLa | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1PO | 9 | 10 | 9 | 10 |
| D1S1656 | 12 | 15 | 12 | 15 |
| D2S1338 | 17 | 17 | ||
| D3S1358 | 15 | 18 | 15 | 18 |
| D5S818 | 11 | 12 | 11 | 12 |
| D6S1043 | 18 | 18 | ||
| D7S820 | 8 | 12 | 8 | 12 |
| D8S1179 | 12 | 13 | 12 | 13 |
| D12S391 | 20 | 25 | 20 | 25 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 10 | 9 | 10 |
| D18S51 | 16 | 16 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 27 | 28 | 27 | 28 |
| FGA | 18 | 21 | 18 | 21 |
| Penta D | 8 | 15 | 8 | 15 |
| Penta E | 7 | 17 | 7 | 17 |
| TPOX | 8 | 12 | 8 | 12 |
| VWA | 16 | 18 | 16 | 18 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying TRIM21 function, TRIM21 Knockout HeLa Cell Line or TRIM21 overexpression HeLa Cell Line?
The choice depends on whether you are studying TRIM21's role in intracellular antibody-mediated immunity or its use as the molecular basis for Trim-Away technology. The Knockout line is essential for both — particularly in HeLa, where Trim-Away technology was originally developed and is most extensively validated. Overexpression is useful for boosting Trim-Away efficiency when endogenous TRIM21 is limiting or for studying the consequences of constitutive TRIM21 elevation.
For Trim-Away methodology research, the EDITGENE TRIM21 Knockout in HeLa is a critical reference tool — it serves as the negative control demonstrating Trim-Away dependency on TRIM21, and as a clean background for reconstituting Trim-Away with engineered TRIM21 variants. Rescue with wild-type, RING-dead (C16/15A), or Fc-binding-deficient (H433A) TRIM21 dissects the contributions of E3 ligase activity versus antibody binding.
What are the application scenarios for this model?
Primary applications:
• Trim-Away technology: HeLa is the original Trim-Away development context; this knockout serves as the essential negative control for confirming TRIM21-dependent targeted protein degradation in Trim-Away experiments.
• Antibody-mediated degradation studies: rescue experiments with engineered TRIM21 variants to optimize Trim-Away efficiency or expand its applications.
• TRIM21 structure-function studies: rescue with RING-dead (C16/15A) and Fc-binding-deficient (H433A) mutants to dissect E3 ligase versus antibody-binding functions.
• Intracellular antibody immunity: characterization of antibody-coated virus or pathogen detection in HeLa background.
EDITGENE recommends this model for researchers using or developing Trim-Away technology and for mechanistic TRIM21 research in the original methodological context.
Is this TRIM21 Knockout HeLa Cell Line compatible with overexpression rescue experiments?
Yes. TRIM21 rescue experiments are well-characterized given TRIM21's importance in Trim-Away technology:
• Construct design: use a codon-modified TRIM21 sequence with a small C-terminal tag (FLAG, HA). TRIM21 is small (~475 amino acids); N-terminal tags can interfere with the RING domain.
• Trim-Away activity rescue: rescue with wild-type TRIM21 should restore Trim-Away-mediated protein degradation in the knockout background — this is the principal functional readout for HeLa-context rescue.
• Structure-function variants: RING-dead (C16A or C15A) and Fc-binding-deficient (H433A) mutants dissect E3 ligase versus antibody-binding functions.
• Expression level: TRIM21 expression levels affect Trim-Away efficiency — rescue should approximate or moderately exceed endogenous TRIM21 levels for optimal activity.
HeLa transduces efficiently with lentivirus and is the most extensively used cell line for Trim-Away methodology, with established protocols for TRIM21 rescue and engineered variant testing.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download